EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Study protocol: The effect of a low-carbohydrate enteral nutrition formula on postoperative hyperglycemia in non-diabetic patients with esophageal cancer: A randomized exploratory phase II trial (ENLICHE study)

Masayoshi Terayama, Yu Imamura iD, Toru Kitazawa, Naoki Miyazaki, Misuzu Ishii, Kumi Takagi, Kengo Kuriyama, Naoki Takahashi, Masahiro Tamura, Akihiko Okamura, Jun Kanamori, Masayuki Watanabe

PLOS One · 2025

DOI: 10.1371/journal.pone.0325039 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Masayoshi Terayama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Hauptthemen laut MEDLINE: Diet, Carbohydrate-Restricted, Enteral Nutrition, Esophageal Neoplasms, Hyperglycemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japanese Association for Thoracic Surgery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postoperative hyperglycemia in diabetic patients is a widely known risk factor for postoperative infectious complications (PICs) after esophagectomy; however, the significance of glycemic control in non-diabetic patients is less clear. In diabetic patients, early postoperative management of esophagectomy favors low-carbohydrate enteral nutrition (EN) over standard EN to suppress the risk of glycemic spike. Our single-center, randomized phase II trial seeks to test the hypothesis that low-carbohydrate EN can suppress hyperglycemia in non-diabetic patients who undergo esophagectomy. Herewith we present the study protocol.

Methods

A total of 50 patients will be enrolled and randomly assigned (1:1 ratio) to standard or low-carbohydrate EN. Randomization will be stratified by operation time (≥560 vs. < 560 min) and HbA1c (6.0–6.4% vs. < 6.0%). Both EN formula will be fed according to the following protocol: 400 mL/24 h on postoperative day (POD)-1; 800 mL on POD-2; 1200 mL on POD-3 and 1600 mL from POD-4 to POD-8. On POD-9, oral food intake will be initiated. A continuous glucose monitoring (CGM) device will be used to monitor blood glucose levels from POD-1 to −8. The primary outcome is the mean time-in-range (TIR) across the 48 h from POD-1 to −2. TIR is defined as the percentage-time that blood glucose remains within the targeted range of 70−180 mg/dL. The primary analysis will calculate the least squares mean difference in TIR over the 48 h (POD-1 to −2) between the two groups, with p-values calculated to test the null hypothesis that the mean difference between the groups is zero. The secondary outcomes will be as follows: 1) the incidence of PICs and/or other adverse events within 30 days after esophagectomy or during the hospital stay; 2) the number of cases requiring any dose alteration in EN formula during monitoring; 3) the number of cases requiring interventions for hyperglycemia or hypoglycemia; 4) the rates in change of nutritional indicators, such as serum albumin, prealbumin, and total protein levels, during the post-surgical hospital stay (vs. those values on the day of admission); and 5) the following CGM indices in relation to the incidence rate of PICs within 30 days after esophagectomy: the mean values for time-above-range (TAR), area under the curve (AUC), and TIR for each POD or from POD-1 to −8. TAR is defined as the percentage of time of a patient is recorded as having hyperglycemia (>blood glucose level of 180 mg/dL), and is indicative of the frequency and duration of hyperglycemia. AUC, which identifies periods of hyperglycemia and provides a comprehensive picture of glucose variability and control in diabetes management, is defined as the area under the curve over blood glucose level of 180 mg/dL on CGM monitoring.

Discussion

This study is the first to investigate the impact of a low-carbohydrate EN formula on hyperglycemic control during perioperative nutritional management of esophageal cancer. These results will help to outline whether glycemic control should be also considered for non-diabetic patients during hospital care.

Trial registration

This trial has been registered in the Japanese Registry of Clinical Trials (jRCTs031240081).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, Carbohydrate-RestrictedEnteral NutritionEsophageal NeoplasmsHyperglycemiaPostoperative ComplicationsAdultAgedFemaleHumansMaleMiddle AgedBlood GlucoseEsophagectomyRandomized Controlled Trials as TopicClinical Trials, Phase II as Topic

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Diabetology, Endocrinology and Metabolism, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Clinical Trial Planning and Management, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Nutritional management, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

ORCID-Profile: Yu Imamura

Förderung

  • Japanese Association for Thoracic Surgery

Zitieren

APA

Terayama, M., Imamura, Y., Kitazawa, T., Miyazaki, N., Ishii, M., Takagi, K., Kuriyama, K., Takahashi, N., Tamura, M., Okamura, A., Kanamori, J., & Watanabe, M. (2025). Study protocol: The effect of a low-carbohydrate enteral nutrition formula on postoperative hyperglycemia in non-diabetic patients with esophageal cancer: A randomized exploratory phase II trial (ENLICHE study). PLOS One. https://doi.org/10.1371/journal.pone.0325039

Vancouver

Terayama M, Imamura Y, Kitazawa T, Miyazaki N, Ishii M, Takagi K, et al. Study protocol: The effect of a low-carbohydrate enteral nutrition formula on postoperative hyperglycemia in non-diabetic patients with esophageal cancer: A randomized exploratory phase II trial (ENLICHE study). PLOS One. 2025. doi:10.1371/journal.pone.0325039

BibTeX
@article{Terayama2025,
  author = {Terayama, Masayoshi and Imamura, Yu and Kitazawa, Toru and Miyazaki, Naoki and Ishii, Misuzu and Takagi, Kumi and Kuriyama, Kengo and Takahashi, Naoki and Tamura, Masahiro and Okamura, Akihiko and Kanamori, Jun and Watanabe, Masayuki},
  title = {Study protocol: The effect of a low-carbohydrate enteral nutrition formula on postoperative hyperglycemia in non-diabetic patients with esophageal cancer: A randomized exploratory phase II trial (ENLICHE study)},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325039}
}
Kostenlos starten →